204 related articles for article (PubMed ID: 19492316)
21. Health-related quality of life outcomes for patients with immune thrombocytopenic purpura.
Klaassen RJ; Young NL
Ann Hematol; 2010 Jul; 89 Suppl 1():51-4. PubMed ID: 20461516
[TBL] [Abstract][Full Text] [Related]
22. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.
McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
24. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
[TBL] [Abstract][Full Text] [Related]
25. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura.
Chandra J; Ravi R; Singh V; Narayan S; Sharma S; Dutta AK
Hematology; 2006 Apr; 11(2):131-3. PubMed ID: 16753855
[TBL] [Abstract][Full Text] [Related]
26. Routine funduscopy in immune thrombocytopenic purpura-is it really necessary?
Capua T; Cohen N; Anafy A; Greisman D; Levin D; Rimon A
Eur J Pediatr; 2019 Jun; 178(6):957-960. PubMed ID: 30937605
[TBL] [Abstract][Full Text] [Related]
27. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
28. Occult hemorrhage in children with severe ITP.
Flores A; Buchanan GR
Am J Hematol; 2016 Mar; 91(3):287-90. PubMed ID: 26661930
[TBL] [Abstract][Full Text] [Related]
29. Evaluating bleeding severity in immune thrombocytopenia (ITP).
Neunert CE
Ann Hematol; 2010 Jul; 89 Suppl 1():47-50. PubMed ID: 20309688
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in children with newly diagnosed immune thrombocytopenia.
Heitink-Pollé KM; Haverman L; Annink KV; Schep SJ; de Haas M; Bruin MC
Haematologica; 2014 Sep; 99(9):1525-31. PubMed ID: 24951468
[TBL] [Abstract][Full Text] [Related]
31. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
Buchanan GR; Adix L
J Pediatr; 2002 Nov; 141(5):683-8. PubMed ID: 12410198
[TBL] [Abstract][Full Text] [Related]
32. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.
McMillan R; Bussel JB; George JN; Lalla D; Nichol JL
Am J Hematol; 2008 Feb; 83(2):150-4. PubMed ID: 17722072
[TBL] [Abstract][Full Text] [Related]
33. Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.
Shimano KA; Neunert C; Bussel JB; Klaassen RJ; Bhat R; Pastore YD; Lambert MP; Bennett CM; Despotovic JM; Forbes P; Grace RF
Pediatr Blood Cancer; 2021 Jun; 68(6):e29023. PubMed ID: 33764667
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
Piel-Julian ML; Mahévas M; Germain J; Languille L; Comont T; Lapeyre-Mestre M; Payrastre B; Beyne-Rauzy O; Michel M; Godeau B; Adoue D; Moulis G;
J Thromb Haemost; 2018 Sep; 16(9):1830-1842. PubMed ID: 29978544
[TBL] [Abstract][Full Text] [Related]
35. Fatigue in children and adolescents with immune thrombocytopenia.
Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.
Snyder CF; Mathias SD; Cella D; Isitt JJ; Wu AW; Young J
Curr Med Res Opin; 2008 Oct; 24(10):2767-76. PubMed ID: 18715526
[TBL] [Abstract][Full Text] [Related]
37. Childhood acute immune thrombocytopenic purpura: 20 years later.
Blanchette VS; Carcao M
Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
[TBL] [Abstract][Full Text] [Related]
38. Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP).
Kumar M; Lambert MP; Breakey V; Buchanan GR; Neier M; Neufeld EJ; Kempert P; Neunert CE; Nottage K; Klaassen RJ;
Pediatr Blood Cancer; 2015 Dec; 62(12):2223-5. PubMed ID: 26174203
[TBL] [Abstract][Full Text] [Related]
39. Clinical variations between three different causes of thrombocytopenia.
Akin S; Haznedaroglu IC
Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020
[TBL] [Abstract][Full Text] [Related]
40. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
